PHR Insider Notice: 18,573 Shares Scheduled for Sale on NYSE

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filed a Form 144 notifying a proposed sale of 18,573 common shares valued at $564,055.11, with an approximate sale date of 08/25/2025 on the NYSE through Fidelity Brokerage Services LLC. The filing lists the shares being sold as previously acquired through restricted stock vesting between Jan 15, 2022 and Jan 15, 2023, with individual vesting lots totaling 18,573 shares. The filer also reported a recent sale on 07/17/2025 of 640 shares for $1,206.91. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Transaction transparency: The filing provides explicit lot-level acquisition dates and amounts for all 18,573 vested shares to be sold.
• Use of brokered market sale: Planned execution through Fidelity Brokerage Services on the NYSE indicates orderly, regulated disposition.

Negative

• Insider selling: A planned sale of 18,573 shares valued at $564,055.11 may be interpreted by some investors as insider liquidity rather than confidence in near-term share appreciation.
• No 10b5-1 plan date disclosed: The filing does not state a trading-plan adoption date, so the sale lacks an explicit pre-committed plan disclosure in this notice.

Insights

Securities Analyst

TL;DR: Routine insider notice for a planned sale of vested restricted shares worth about $564k; limited immediate informational impact.

The filing is a standard Rule 144 notice documenting an intended sale of 18,573 common shares acquired via restricted stock vesting across 2022–2023. The sale is scheduled through a broker on the NYSE and follows a small sale of 640 shares earlier in July 2025. This is a compliance disclosure rather than an operational update and does not itself provide new financial performance data. Investors should view this as an insider liquidity event based on prior compensation grants, not a change in corporate guidance or capital structure.

Corporate Governance Specialist

TL;DR: Compliance-focused filing showing insider exercising liquidity on vested equity; governance implications are routine.

The notice indicates the seller is disposing of shares originating from compensation (restricted stock vesting), with specific grant dates and lot sizes disclosed. The signature block includes the required representation about material nonpublic information. From a governance perspective, this is consistent with expected post-vesting sales and documented trading through a broker. The filing contains no statements of a 10b5-1 plan adoption date, so there is no explicit trading-plan protection disclosed here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	18573	564055.11	59504269	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2022	Restricted Stock Vesting	Issuer			5061	01/15/2022	Compensation
Common	01/17/2022	Restricted Stock Vesting	Issuer			906	01/17/2022	Compensation
Common	04/13/2022	Restricted Stock Vesting	Issuer			1886	04/13/2022	Compensation
Common	04/14/2022	Restricted Stock Vesting	Issuer			994	04/14/2022	Compensation
Common	07/14/2022	Restricted Stock Vesting	Issuer			783	07/14/2022	Compensation
Common	09/12/2022	Restricted Stock Vesting	Issuer			1032	09/12/2022	Compensation
Common	10/14/2022	Restricted Stock Vesting	Issuer			783	10/14/2022	Compensation
Common	01/14/2023	Restricted Stock Vesting	Issuer			709	01/14/2023	Compensation
Common	01/15/2023	Restricted Stock Vesting	Issuer			6419	01/15/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amy Vanduyn 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	640	1206.91

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia's Form 144 disclose about the planned sale?

The Form 144 discloses a proposed sale of 18,573 common shares valued at $564,055.11, with an approximate sale date of 08/25/2025, to be executed on the NYSE through Fidelity Brokerage Services.

How were the shares being sold acquired according to the filing?

All shares scheduled for sale were acquired as restricted stock vesting between 01/15/2022 and 01/15/2023 as compensation from the issuer.

Did the filer recently sell any shares prior to this notice?

Yes, the filing reports a prior sale on 07/17/2025 of 640 shares for gross proceeds of $1,206.91.

Is there any statement about material nonpublic information in the Form 144?

Yes, the notice includes the required representation that the person selling the securities does not know of any material adverse information about the issuer that has not been publicly disclosed.